Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 2313Glioblastoma 2016Glioma 1402Central Nervous System Neoplasms 692Astrocytoma 668Neuroblastoma 647Gliosarcoma 480Oligodendroglioma 405Neoplasms 405Breast Neoplasms 327Medulloblastoma 307Carcinoma, Non-Small-Cell Lung 256Meningioma 229Recurrence 224Sarcoma 215Melanoma 207Neoplasm Metastasis 202Ependymoma 200Lung Neoplasms 199Neurofibromatosis 1 169Lymphoma 162Meningeal Carcinomatosis 138Osteosarcoma 135Ovarian Neoplasms 132Wilms Tumor 123Precursor Cell Lymphoblastic Leukemia-Lymphoma 123Head and Neck Neoplasms 117Lymphoma, Non-Hodgkin 116Diffuse Intrinsic Pontine Glioma 113Rhabdomyosarcoma 107

Interventions

perampanel 1Diet, Ketogenic 1Anticonvulsants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Drug Resistant Epilepsy × CNS × Clear all
NCT06309251 2025-09-03

Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients

Danone Nutricia SpA Società Benefit

Recruiting
100 enrolled
CNS

Autism Spectrum Disorder, Drug Resistant Epilepsy, Brain Neoplasms

NCT04650204 2023-06-22

Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy

Mayo Clinic

Phase 4 Terminated
4 enrolled 9 charts
CNS

Drug Resistant Epilepsy, Epilepsy, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡